A new analysis conducted at the Centre Leon Gerard in Lyon, France has unveiled that cancer patients shoed a significantly lower detection rate of SARS-COV2 antibodies compared to healthcare workers 15 days or more after first exhibiting COVID-19 symptoms. According to study reports led by Professor Jean-Yves Blay, "5 of 75 patents with cancer (5.9%) and 13 of 244 healthcare workers (5.4%) had detectable antibodies against COVID-19." The study further claims that patients receiving anti-cancer treatment 1 month prior to being tested for COVID-19 had a higher rate of undetectable antibodies.
To read more about this study, click here.
No comments:
Post a Comment